Bob joined Horizon Pharma in March 2014 as chief business officer. Prior to joining Horizon Pharma, he spent more than 11 years as managing director and head of the life sciences investment banking group at JMP Securities LLC, a full-service investment bank. Prior to JMP, Bob was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities. He also has held roles at Red Hen Bread, InStadium, Shearson Lehman Hutton and Ernst & Whinney. Bob has assisted biotech and specialty pharma companies raise more than $10 billion in initial public offerings, follow-on offerings, debt offerings and private placements. He has also served as a financial advisor on mergers, acquisitions and strategic alliance transactions with a total deal value of more than $3 billion.

Bob joined Horizon Pharma in March 2014 as chief business officer. Prior to joining Horizon Pharma, he spent more than 11 years as managing director and head of the life sciences investment banking group at JMP Securities LLC, a full-service investment bank. Prior to JMP, Bob was a managing director in the healthcare groups at Dresdner Kleinwort Wasserstein and Vector Securities. He also has held roles at Red Hen Bread, InStadium, Shearson Lehman Hutton and Ernst & Whinney. Bob has assisted biotech and specialty pharma companies raise more than $10 billion in initial public offerings, follow-on offerings, debt offerings and private placements. He has also served as a financial advisor on mergers, acquisitions and strategic alliance transactions with a total deal value of more than $3 billion.